| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.065 | 0.4 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.054 | 0.4 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.1 | 0.4 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.4 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.4 |